BioLife Solutions Inc.

NASDAQ: BLFS · Real-Time Price · USD
21.95
-2.25 (-9.30%)
At close: May 06, 2025, 3:59 PM
21.95
-0.02%
After-hours: May 06, 2025, 04:05 PM EDT
-9.30%
Bid 19
Market Cap 1.04B
Revenue (ttm) 87.2M
Net Income (ttm) -20.18M
EPS (ttm) -0.25
PE Ratio (ttm) -87.82
Forward PE 186.31
Analyst Buy
Ask 27.8
Volume 1,108,353
Avg. Volume (20D) 465,471
Open 24.35
Previous Close 24.20
Day's Range 21.41 - 24.53
52-Week Range 17.15 - 29.55
Beta 2.01

About BLFS

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are form...

Sector Healthcare
IPO Date Nov 22, 1989
Employees 159
Stock Exchange NASDAQ
Ticker Symbol BLFS
Full Company Profile

Analyst Forecast

According to 7 analyst ratings, the average rating for BLFS stock is "Buy." The 12-month stock price forecast is $31, which is an increase of 41.20% from the latest price.

Stock Forecasts

Next Earnings Release

BioLife Solutions Inc. is scheduled to release its earnings on May 8, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription